Purdue Pharma, Opioid epidemic

The latest on the Purdue Pharma and Sackler family opioid settlement
A new $7.4 billion settlement with states has been reached with Purdue Pharma and its Sackler family owners. We'll unpack.
Sackler family, Purdue Pharma reach $7.4 billion settlement with 15 states over opioid crisis
The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis, New York Attorney General Letitia James announced Thursday.
Sackler, Purdue Pharma $7 Billion Lawsuit: Who's Entitled to Payment
The Office of the Attorney General came to a $7.4 billion settlement with the Sackler family and their company, Purdue Pharma, over their actions leading up to the opioid crisis, which has killed several hundreds of thousands of people in the last two decades.
Purdue Pharma owners strike new $6.5 billion deal in opioid case
The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family members from future lawsuits.
Attorney General Raoul Helps Secure $7.5 Billion From Purdue Pharma And The Sackler Family For Fueling Opioid Crisis
CHICAGO - Attorney General Kwame Raoul, along with a bipartisan coalition of states and other parties, today announced a $7.4 billion settlement in principle
Sackler family, Purdue Pharma agree to pay $7.4B to settle opioid suit by 15 states
The Sackler family and Purdue Pharma have agreed to pay a $7.4 billion settlement to end federal court claims filed by attorneys general on behalf of 15 states.
Pennsylvania to get $212 million from opioids settlement with Purdue Pharma, Sackler family
Pennsylvania may receive up to $212 million over 15 years as part of a multi-state lawsuit settlement with Purdue Pharma and the Sackler family, its owners, for their roles in the opioid overdose crisis.
Delaware slated to receive over $27M in settlement with Purdue Pharma, Sackler family
A settlement reached with the Sackler family and Purdue Pharma will bring over $27 million to the First State, roughly half of what was originally anticipated before a Supreme Court decision put settlement funds in limbo last year.
Purdue and Sackler family agree to $7.4bn national opioid settlement
Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in fuelling the opioid epidemic in the country.
Purdue Pharma, Sackler families boost contribution in opioid settlement to $7.4 billion
Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.
Bankrupt Purdue buys time to advance $7.4 billion opioid deal
Purdue Pharma said on Friday it needs more time to build support for a new $7.4 billion settlement that could complete the company's years-long effort to resolve thousands of lawsuits over its addictive pain medication OxyContin.
More than $100 million expected in Mass. from $7.4 billion settlement with Purdue Pharma, Sacklers
OxyContin maker Purdue Pharma and its owners agreed to pay up to $7.4 billion in a new settlement, officials in Mass. and ...
FiercePharma3d
Sackler family, Purdue Pharma boost multistate opioid settlement to $7.4B in new agreement
In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the ...